Marson T. The SANAD II study of effectiveness of valproate or levetiracetam in generalised and unclassifiable epilepsy: an un-blinded randomised controlled trial. 5th European Academy of Neurology (EAN) Congress, abstract O4125.
Nieuwe cijfers Alzheimer Europe: aantal mensen met dementie in 2050 verdubbeld
feb 2020 | Dementie